title: [Induction of hospital indebtedness due to medicine purchases under monopoly conditions: the case of imatinib mesylate].
abstract: Medicine expenditures consume a large share of the health budget, so knowledge on the use of these funds is essential for decision-making in public health and improvement of pharmaceutical care. This study analyzed the indebtedness of a high-complexity university hospital due to increased spending on imatinib mesylate. The descriptive study was based on analysis of documents and records in the Hospital Information System (SIH) from 2002 to 2010. Starting with inclusion of the medicine in the budget, the study mapped strategies by the pharmaceutical industry and government, as well as government responses to reduce the product's price. The systematization and publication of information stored in files and electronic databases can help monitor the results of programs funded by the Brazilian Ministry of Health.
authors: Carolinne Thays
authors: CT
authors: Scopel
authors: Gabriela Costa
authors: GC
authors: Chaves
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D001549:Benzamides / Q000191:economics* / Q000627:therapeutic use; D001938:Brazil; D002017:Budgets; D016527:Drug Costs; D005102:Health Expenditures / Q000639:trends; D006291:Health Policy / Q000191:economics; D017721:Hospital Costs / Q000458:organization & administration*; D006779:Hospitals, Public / Q000191:economics*; D006785:Hospitals, University / Q000191:economics*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000191:economics* / Q000627:therapeutic use; D011743:Pyrimidines / Q000191:economics* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate